Biopesticide Opportunity Target public health agencies and vector control districts that are active in field trials or expanding sterile insect technique programs. MosquitoMate’s natural bacterium-based sterilization approach can complement or replace chemical controls in areas battling Aedes aegypti and Zika-linked outbreaks.

Field Trial Value Leverage ongoing and upcoming field trials in Florida Keys and similar high-risk regions to initiate pilots with municipal vector control teams. Emphasize measurable impact on local populations and potential to scale without extensive chemical reliance.

SMB to Enterprise Path Position MosquitoMate as a scalable, low-headcount R&D and services partner for mid-market agencies and larger health departments seeking innovative, sustainable mosquito control solutions with simpler deployment compared to traditional pest control providers.

Strategic Partnerships Cultivate collaborations with university labs, public health researchers, and state environmental agencies to co-develop protocols, performance data, and funding opportunities that can drive broader adoption and longer-term contracts.

Funding Readiness Highlight the company’s revenue trajectory and growth potential to attract grants, public funding, or strategic investors. Use demonstrated field trial activity to support proposals for scalable projects and expanded geographic reach.